Download content by Baxter BioPharma Solutions.

Process Development for Lyophilized Products

Baxter BioPharma Solutions approaches formulation and process development with the intention of identifying the failure points for the product. Knowing where...

Read More

Manufacturing of Cytotoxic and Non-Cytotoxic Drugs in a Multiproduct Facility

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

Read More

SCALE-UP AND TECHNICAL TRANSFER FOR LYOPHILIZED PRODUCTS

Formulation and process development for injectable products are typically conducted at laboratory-scale. There are few challenges when increasing the scale of...

Read More